These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9812253)

  • 1. Boric acid vaginal suppositories: a brief review.
    Prutting SM; Cerveny JD
    Infect Dis Obstet Gynecol; 1998; 6(4):191-4. PubMed ID: 9812253
    [No Abstract]   [Full Text] [Related]  

  • 2. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C; Gkegkes ID; Zarkada IM; Falagas ME
    J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boric acid for yeast infections.
    Health News; 2001 Jun; 7(6):7. PubMed ID: 11851172
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.
    Jovanovic R; Congema E; Nguyen HT
    J Reprod Med; 1991 Aug; 36(8):593-7. PubMed ID: 1941801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial effect of boric acid on Trichomonas vaginalis.
    Brittingham A; Wilson WA
    Sex Transm Dis; 2014 Dec; 41(12):718-22. PubMed ID: 25581807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S; De Seta F; Sartore A; Ricci G; De Santo D; Piccoli M; Alberico S
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M; Trouton KM
    Trials; 2015 Jul; 16():315. PubMed ID: 26210791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.
    Shinohara YT; Tasker SA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):219-20. PubMed ID: 9390576
    [No Abstract]   [Full Text] [Related]  

  • 11. FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.
    Khameneie KM; Arianpour N; Roozegar R; Aklamli M; Amiri MM
    East Afr Med J; 2013 Apr; 90(4):117-23. PubMed ID: 26866095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical drugs for vaginal candidiasis.
    Med Lett Drugs Ther; 1991 Aug; 33(851):81. PubMed ID: 1865851
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatitis toxica faciei after boric acid.
    Jiráková A; Rajská L; Rob F; Gregorová J; Hercogová J
    Dermatol Ther; 2015; 28(1):52-5. PubMed ID: 25314158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terconazole for Candida vaginitis.
    Med Lett Drugs Ther; 1988 Dec; 30(782):118-9. PubMed ID: 3200220
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories.
    Thirion DJ; Zanetti LA
    Pharmacotherapy; 2000 Jan; 20(1):98-9. PubMed ID: 10641982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terconazole for the treatment of vulvovaginal candidiasis.
    Thomason JL; Gelbart SM; Kellett AV; Scaglione NJ; Gotwalt KT; Broekhuizen FF
    J Reprod Med; 1990 Nov; 35(11):992-4. PubMed ID: 2277372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of vulvovaginal candidiasis with boric acid powder.
    Van Slyke KK; Michel VP; Rein MF
    Am J Obstet Gynecol; 1981 Sep; 141(2):145-8. PubMed ID: 7282789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
    Sobel JD; Chaim W; Nagappan V; Leaman D
    Am J Obstet Gynecol; 2003 Nov; 189(5):1297-300. PubMed ID: 14634557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boric acid vaginal suppositories.
    Thai L; Hart LL
    Ann Pharmacother; 1993 Nov; 27(11):1355-7. PubMed ID: 8286810
    [No Abstract]   [Full Text] [Related]  

  • 20. Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid.
    Silverman NS; Morgan M; Nichols WS
    Infect Dis Obstet Gynecol; 2001; 9(4):245-7. PubMed ID: 11916183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.